News search

    E.g., 25/11/2024
    E.g., 25/11/2024
    Valentín Fuster
    Research
    26 Aug 2022
    NEJM: The polypill reduces cardiovascular mortality by 33% in patients treated after myocardial infarction

    The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM

    Participants who followed the TANSNIP-PESA program (orange line) showed an improvement in lifestyle measures and cardiovascular health compared with participants in the control group (who did not participate in the intervention; blue line). The Y-axis shows changes in the Fuster -BEWAT lifestyle and cardiovascular risk score with respect to the baseline value.
    Research
    26 Jul 2022
    European Heart Journal: “One change a day makes 365 changes in a year”

    Adherence to a workplace cardiovascular health-promotion program improves lifestyle and risk factors in healthy individuals
    Andrés Hidalgo
    About the CNIC
    6 Jul 2022
    Dr. Andrés Hidalgo elected a member of the European Molecular Biology Organization – EMBO

    Through this lifelong honour, new EMBO Members and Associate Members are recognized for their outstanding achievements in the life sciences
    Imagen
    About the CNIC
    29 Jun 2021
    RESILIENCE, a project to reduce the prevalence of heart failure in cancer survivors

     Over one million European cancer patients suffer from side effects to chemotherapy
    Dr. Miguel Torres
    About the CNIC
    10 May 2021
    Dr. Miguel Torres appointed Associate Editor of Science Advances

    Dr. Torres is a member of the European Molecular Biology Organization (EMBO). Dr. Miguel Torres’s scientific research focuses on the regulation of embryonic development and the formation and regeneration of organs.

    Marta Amorós Pérez, Virginia Zorita, Nuria Matesanz, Marian Zuriaga y José Javier Fuster.
    About the CNIC
    23 Dec 2020
    CNIC to coordinate a European project investigating how cancer therapies promote atherosclerosis and cardiovascular disease

    The project will investigate the role of clonal hematopoiesis—the formation of mutated hematopoietic stem-cell clones promoted by anti-cancer therapies—in the development of atherosclerosis and associated cardiovascular disease
    Irene Fernández-Nueda, Carlos Cerón y Marta Cortés-Canteli
    About the CNIC
    15 Dec 2020
    CNIC scientists coordinate a European project to develop a biomarker for the early identification of the vascular component in Alzheimer disease

    The BioClotAD project, coordinated by CNIC scientist Dr Marta Cortés Canteli, has been selected by the EU Joint Programme – Neurodegenerative Disease Research (JPND)
    Research
    9 Oct 2020
    EHJ: Metoprolol: an old drug with unique cardioprotective properties

    CNIC scientists have defined the unique ability if metoprolol to protect the heart during a heart attack
    About the CNIC
    31 Aug 2020
    The CNIC one of the four Leading Cardiovascular Research Centers in Europe at the 2020 European Congress of Cardiology
    About the CNIC
    12 Dec 2019
    Jacob Fog Bentzon receives 2 M euros from the European Research Council for a ground-breaking research project on atherosclerosis

    Professor Jacob Fog Bentzon from Aarhus University and the CNIC  receives 2 M euros from the European Research Council for a ground-breaking research project on atherosclerosis – one of the most frequent causes of death in the world